A phase I, dose-escalation study of the novel Polo-like kinase inhibitor volasertib (BI 6727) in patients with advanced solid tumours

出版年份 2011 全文链接

标题

作者

关键词

出版物

Volume 48, Issue 2, Pages 179-186

出版商

Elsevier BV

发表日期

2011-11-30

DOI

10.1016/j.ejca.2011.11.001

Discuss science. Find collaborators. Network.

Join a conversation

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started